Health Economics

1992 - 2025

Current editor(s): Alan Maynard, John Hutton and Andrew Jones

From John Wiley & Sons, Ltd.
Bibliographic data for series maintained by Wiley Content Delivery ().

Access Statistics for this journal.
Is something missing from the series or not right? See the RePEc data check for the archive and series.

Volume 7, issue S1, 1998

Editors' foreword pp. S1-S2

Alan Maynard and Cam Donaldson

Primeval health economics in Britain: A personal retrospect of the pre‐HESG period pp. S3-S8

Alan Williams

From private club to professional network: An economic history of the Health Economists' Study Group, 1972–1997 pp. S9-S45

Bronwyn Croxson

The impact of health economics on health policy in England, and the impact of health policy on health economics, 1972–1997 pp. S47-S61

Jeremy Hurst

Where are we now in British health economics? pp. S63-S78

Mark Blaug

US and UK health economics: Two disciplines separated by a common language? pp. S79-S92

Joseph Newhouse

Volume 7, issue 8, 1998

The role of government in health insurance markets with adverse selection pp. 659-670

Roger Feldman, Carlos Escribano and Laura Pellisé

Insurance effects on US medical spending (1960–1993) pp. 671-687

Edgar A. Peden and Mark S. Freeland

Drinking patterns within households: the estimation and interpretation of individual and group variables pp. 689-699

Nigel Rice and Matthew Sutton

Estimation of a multiproduct cost function for physically frail older people pp. 701-710

Paul McNamee, Barbara A. Gregson, Ken Wright, Debbie Buck, Claire H. Bamford and John Bond

General practitioners' referral thresholds and choices of referral destination: an experimental study pp. 711-722

Stephen C. Earwicker and David K. Whynes

Confidence intervals or surfaces? Uncertainty on the cost‐effectiveness plane pp. 723-740

Andrew Briggs and Paul Fenn

Letter to the editors pp. 741-742

Michael T. Halpern, Michael Mckenna and John Hutton

Volume 7, issue 7, 1998

Medicine, economics, ethics and the NHS: a clash of cultures? pp. 565-568

Alan Williams

Paying patients to comply: an economic analysis pp. 569-579

Antonio Giuffrida and Hugh Gravelle

Discounting costs and effects: a reconsideration pp. 581-594

Ben A. Van Hout

Magnetic resonance imaging for the investigation of knee injuries: an investigation of preferences pp. 595-603

Stirling Bryan, Martin Buxton, Robert Sheldon and Alison Grant

An investment appraisal approach to clinical trial design pp. 605-619

Martin E. Backhouse

On the measurement of the nation's equity adjusted health pp. 621-628

Lars Lindholm and Måns Rosén

Resource costing for multinational neurologic clinical trials: methods and results pp. 629-638

Kevin Schulman, Jennifer Burke, Michael Drummond, Linda Davies, Per Carlsson, Jans Gruger, Anthony Harris, Carlo Lucioni, Ramon Gisbert, Ted Llana, Eric Tom, Bernard Bloom, Richard Willke and Henry Glick

The impact of ownership type on nursing home outcomes pp. 639-653

William D. Spector, Thomas M. Selden and Joel W. Cohen

Rachel Rosser pp. 655-656

Paul Kind

Towards the equitably efficient and transparently decidable use of public funds in the deep blue millennium—a view from the front line pp. 657-657

D.P. Kernick

Volume 7, issue 6, 1998

Estimating country‐specific cost‐effectiveness from multinational clinical trials pp. 481-493

Richard J. Willke, Henry A. Glick, Daniel Polsky and Kevin Schulman

More physicians: improved availability or induced demand? pp. 495-508

Fredrik Carlsen and Jostein Grytten

Price elasticities of demand for curative health care with control for sample selectivity on endogenous illness: an analysis for Sri Lanka pp. 509-531

John Akin, David K. Guilkey, Paul L. Hutchinson and Michael T. McIntosh

The black box of health care expenditure growth determinants pp. 533-544

Pedro Barros

Referral rates and waiting lists: some empirical evidence pp. 545-549

J.A. Goddard and M. Tavakoli

Economic evaluation in schistosomiasis: valuation of health states preferences: a research note pp. 551-556

Joses Muthuri Kirigia

Choice of hospital: comments on ‘global budgets and excess demand for hospital care’ pp. 557-559

N. Kalant

Book Review: The economic aspects of biotechnologies related to human health. Part 1: Biotechnology and medical innovations: socio‐economic assessments of the technology, the potential and the products by the Organization for Economic Cooperation and Development, Paris, 1997. No. of pages: 265. OECD/GD(97)205 pp. 561-562

David Hailey

Book Review: OHE compendium of health statistics. OHE, 12 Whitehall, London SW1A 2DY, 1997 pp. 562-562

Alan Maynard

Book Review: Quality of life assessments in clinical trials: methods and practice by M.J. Staquet, R.D. Hays AND P.M. Fayers. Oxford University Press, Oxford, 1998. No. of pages: 360. ISBN 0 192 62785 6 pp. 562-563

Paul Donlan

Volume 7, issue 5, 1998

Guest editors' introduction pp. 379-380

Andrew Jones and Owen O'Donnell

Early health‐related behaviours and their impact on later life chances: evidence from the US pp. 381-399

Simon M. Burgess and Carol Propper

Participation, heterogeneity and dynamics in tobacco consumption: evidence from cohort data pp. 401-414

Sergi Jiménez‐Martín, Jose Labeaga and Angel López

Measuring hospital cost efficiency with panel data models pp. 415-427

Miika Linna

Unobserved heterogeneity and censoring in the demand for health care pp. 429-437

Angel López‐Nicolás

Controlling for the endogeneity of peer substance use on adolescent alcohol and tobacco use pp. 439-453

Edward Norton, Richard Lindrooth and Susan T. Ennett

The efficient organization of blood donation pp. 455-463

Marjon van der Pol and John A. Cairns

Risk adjustment and the trade‐off between efficiency and risk selection: an application of the theory of fair compensation pp. 465-480

Erik Schokkaert, Geert Dhaene and Carine Van De Voorde

Volume 7, issue 4, 1998

Private sector health reform in South Africa pp. 281-289

Alexander Marius Van Den Heever

An econometric study of costs of teaching and research in Finnish hospitals pp. 291-305

Miika Linna, Unto Häkkinen and Eero Linnakko

Using the person trade‐off approach to examine differences between individual and social values pp. 307-312

Paul Dolan and Colin Green

Health care contingent valuation studies: a review and classification of the literature pp. 313-326

Alan Diener, Bernie O'Brien and Amiram Gafni

Sample size calculation in economic evaluations pp. 327-335

Maiwenn J. Al, Ben A. Van Hout, Bowine C. Michel and Frans F.H. Rutten

Financing health services in Poland: new evidence on private expenditures pp. 337-346

Mukesh Chawla, Peter Berman and Dorota Kawiorska

Substitution of physicians and other providers in outpatient mental health care pp. 347-361

Partha Deb and Ann M. Holmes

Cost efficiency, factor interchange, and technical progress in US specialized hospital pharmacies pp. 363-371

Albert Okunade and Chutima Suraratdecha

Methodological issues in the application of conjoint analysis in health care pp. 373-378

Mandy Ryan, Emma McIntosh and Phil Shackley

Volume 7, issue 3, 1998

Competition in the NHS internal market: an overview of its effects on hospital prices and costs pp. 187-197

Carol Propper and Neil Söderlund

Volume responses to medicare payment reductions with multiple payers: a test of the McGuire–Pauly model pp. 199-219

Ming Tai‐Seale, Thomas H. Rice and Sally Stearns

Use of economic evaluation guidelines: 2 years' experience in Canada pp. 221-227

Jean‐François Baladi, Devidas Menon and Nicolaas Otten

Drug use, drug abuse, and labour market outcomes pp. 229-245

Thomas Buchmueller and Samuel H. Zuvekas

Effects of selective contracting on hospital efficiency, costs and accessibility pp. 247-261

Lee Rivers Mobley

Technical efficiency in the clinical management of critically ill patients pp. 263-277

Jaume Puig‐Junoy

Book review: Statistical issues in drug development by Stephen Senn. John Wiley & Sons, Chichester, 1997. No. of pages: 423. ISBN: 0 471 97488 9 pp. 279-279

Sean Mcguigan

Book review: non‐Random reflections on health services research edited by Alan Maynard and Iain Chalmers. BMJ Publishing Group, London, 1997. No. of pages: 303. ISBN: 0‐7279‐1151‐1 pp. 280-280

Charles Normand

Volume 7, issue 2, 1998

Towards the equitably efficient and transparently decidable use of public funds in the deep blue millennium pp. 93-103

Jack Dowie

From competition to co‐operation: new economic relationships in the National Health Service pp. 105-119

Maria Goddard and Russell Mannion

Discounting life‐years: whither time preference? pp. 121-127

Dorte Gyrd‐Hansen and Jes Søgaard

The cost‐effectiveness of preference‐based treatment allocation: the case of hysterectomy versus endometrial resection in the treatment of menorrhagia pp. 129-142

Mark Sculpher

Bootstrap confidence intervals for cost‐effectiveness ratios: some simulation results pp. 143-147

Magnus Tambour and Niklas Zethraeus

Introduction to the special issue on competition and antitrust policy in health care markets pp. 161-162

Deborah Haas‐Wilson and Martin Gaynor

Health economics research and antitrust enforcement pp. 163-166

Louis Silvia and Robert F. Leibenluft

Emerging issues in the antitrust definition of healthcare markets pp. 167-170

David Dranove and William D. White

HMO mergers and medicare: the antitrust issues pp. 171-174

Roger Feldman and Ruth S. Given

Exclusive contracts between hospitals and physicians: the antitrust issues pp. 175-178

Harry Frech and Kenneth L. Danger

Physician networks and their implications for competition in health care markets pp. 179-182

Deborah Haas‐Wilson and Martin Gaynor

An introduction to Health Economics for Eastern Europe and the Former Soviet Union by S. Witter and T. Ensor pp. 183-183

Anne Mills

Volume 7, issue 1, 1998

Editorial: Some reflections on cost‐effectiveness analysis pp. 1-7

Magnus Johannesson and David Meltzer

Colorectal cancer screening: efficiency and effectiveness pp. 9-20

Dorte Gyrd‐Hansen, Jes Søggard and Ole Kronborg

Faecal occult blood screening for colorectal cancer: is it cost‐effective? pp. 21-29

David K. Whynes, Aileen R. Neilson, Andrew R. Walker and Jack D. Hardcastle

Willingness to pay for hormone replacement therapy pp. 31-38

Niklas Zethraeus

Health economic assessment of behavioural rehabilitation in chronic low back pain: a randomised clinical trial pp. 39-51

Mariëlle E.J.B. Goossens, Maureen P.M.H. Rutten‐ Van Mölken, Ank M.J. Kole‐Snijders, Johan W.S. Vlaeyen, Gerard Van Breukelen and Reiner Leidl

Casemix‐based funding of Northern Territory public hospitals: adjusting for severity and socio‐economic variations pp. 53-61

Carol Beaver, Yuejen Zhao, Stewart McDermid and Don Hindle

The effect of employment status on private health insurance coverage: 1977 and 1987 pp. 63-79

Sherrie L.W. Rhine and Ying Chu Ng

The economic costs of illicit drug use in Ontario, 1992 pp. 81-85

Xiaodi Xie, Jürgen Rehrn, Eric Single, Lynda Robson and Josh Paul

Book Review: Managed Care: Practice and Progress. Robert Royce. Radcliffe Medical Press, Oxford and New York, 1997. 236 pp. ISBN 1‐85775‐280‐5 pp. 87-87

Ray Robinson

Book Review: Making Choices for Health Care. Frank Honigsbaum, Stefan Holmstrom, Johan Calltorp, Radcliffe Medical Press, Abingdon, 1997. 131 pp. ISBN 1‐85775‐251‐1 pp. 88-88

Joanna Coast

Book Review: Public Health at the Crossroads. Robert Beaglehole and Ruth Bonita. Cambridge University Press, Cambridge, 1997. 243 pp. ISBN 0‐521‐58665‐8 pp. 88-89

Angela Coulter

Book Review: Promoting Cost‐Effective Prescribing in the UK National Health Service. eds. Karen Bloor and Nick Freemantle. Centre for Health Economics, University of York, York. 1996. 112 pp. ISBN 0‐9525601‐1‐9 pp. 89-90

Mo Malek